The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.
 
Katherine B. Peters
Consulting or Advisory Role - Agios; Bayer
Research Funding - Abbvie; Agios; BioMimetix; Novocure
 
John L. Villano
No Relationships to Disclose
 
Nicholas A. Butowski
Stock and Other Ownership Interests - Cordance; Cordance
Consulting or Advisory Role - Amgen; Cellinta; DelMar Pharmaceuticals; Karyopharm Therapeutics; KIYATEC; Lynx Group; Plus Therapeutics; QED Therapeutics; Tocagen; VBI Vaccines; VBL Therapeutics
Research Funding - Abbvie (Inst); Amgen; Amgen (Inst); Arbor Pharmaceuticals (Inst); BeiGene (Inst); BeiGene (Inst); BioMimetix (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); EpicentRx; Five Prime Therapeutics; Ipsen; Istari (Inst); KIYATEC (Inst); Medicenna; Merck; Oncoceutics (Inst); Orbus Therapeutics; Tocagen (Inst)
 
Adam Louis Cohen
Research Funding - Abbvie (Inst); Acrotech Biopharma (Inst); AstraZeneca (Inst); BioMimetix (Inst); Bristol-Myers Squibb (Inst); Cantex (Inst); Daiichi Sankyo (Inst); Diffusion Pharmaceuticals (Inst); H3 Biomedicine (Inst); Lilly (Inst); Merrimack (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Joe Sammy Mendez
Expert Testimony - Intermountain Healthcare
 
Pierre Giglio
Stock and Other Ownership Interests - Vanguard Funds
Research Funding - Agios; BioMimetix; Prelude Corporation
 
Chi Zhang
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending
 
Shahzad Raza
Stock and Other Ownership Interests - Abbott Laboratories; Acasti Pharma; Amicus Therapeutics; BioNTech; Durect Corporation; Gilead Sciences; Moderna Therapeutics; Sierra Oncology; Stryker
Consulting or Advisory Role - Celgene; Incyte; Kite, a Gilead company; Novartis; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen; Takeda
Expert Testimony - Celgene; Takeda
 
Tresa McGranahan
No Relationships to Disclose
 
Mina Lobbous
No Relationships to Disclose
 
David MacLeod
Employment - BioMimetix
Stock and Other Ownership Interests - BioMimetix
 
Shayne Gad
Employment - Consultants in Medical Oncology and Hematology
Leadership - BioMimetix
Consulting or Advisory Role - BioMimetix
Travel, Accommodations, Expenses - travel to audit studies or for FDA meetings
 
Sara Penchev
Employment - BioMimetix
Stock and Other Ownership Interests - BioMimetix
Research Funding - BioMimetix
 
David Silberstein
Employment - BioMimetix
Leadership - BioMimetix
Stock and Other Ownership Interests - BioMimetix
Consulting or Advisory Role - BioMimetix
Research Funding - BioMimetix
Patents, Royalties, Other Intellectual Property - BioMimetix
Travel, Accommodations, Expenses - BioMimetix
Other Relationship - BioMimetix
 
James Crapo
Employment - BioMimetix
Leadership - BioMimetix
Stock and Other Ownership Interests - BioMimetix
Research Funding - BioMimetix
Patents, Royalties, Other Intellectual Property - BioMimetix
Travel, Accommodations, Expenses - BioMimetix